Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Bausch & Lomb Ireland withdraws Retisert marketing authorization application

July 27, 2007

Preclinical antiglaucomal efficacy of the novel prostanoid FP receptor agonist tafluprost presented

July 24, 2007

Acadia receives milestone payment for drug candidate for glaucoma

July 20, 2007

Opko Health initiates phase III trial of bevasiranib in wet AMD

July 18, 2007

Jerini Ophthalmic's IND for JSM-6427 for AMD accepted by FDA

July 17, 2007

OT-551 holds promise for oncology and inflammatory conditions

July 13, 2007

SurModics and Merck & Co. sign ophthalmic license and research collaboration

June 29, 2007

Advanced Cell Technology advances retinal pigment epithelial program

June 26, 2007

Once-daily Mikelan LA to launch in Japan

June 21, 2007

OT-551 studied in phase II trial for geographic atrophy

June 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...